Literature DB >> 20186486

Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US.

Ramsey Cheung1, Ajitha Mannalithara, Gurkirpal Singh.   

Abstract

BACKGROUND: Studies on mostly veterans found the majority of chronic hepatitis C (CHC) patients were not treated. Little information exists on a broad-based population. AIMS: To determine the national trend of ambulatory visits with a diagnosis of hepatitis C and the prescription of antiviral therapy associated with such visits.
METHODS: Retrospective analysis of national cross-sectional databases, the National Ambulatory Medical Care Survey (NAMCS), and the National Hospital Ambulatory Medical Care Survey (NHAMCS) encompassing all ambulatory visits from 2000 to 2006.
RESULTS: During the study period, 16.5 million visits (0.21% of all visits) carried a diagnosis of hepatitis C and the number initially increased. Characteristics of the hepatitis C patients were: 65% male; 71% white, 22% black; 69% >or=45 years old. Overall, 47% had private insurance, 24% had Medicaid, and 12% had Medicare. Only 9.1% of these patients were prescribed antiviral treatment for CHC. There was no significant difference between those who received treatment and those who did not in terms of age, gender, race, and insurance status. HIV infection, mood, substance-use disorders, and anemia were more common in the CHC group.
CONCLUSIONS: Less than 10% of the ambulatory visits for hepatitis C were associated with a prescription for antiviral therapy, independent of demographic and insurance status. Purposes of the clinic visits were different in the CHC group compared to the general population. The reason for the low treatment rate is not clear but deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186486     DOI: 10.1007/s10620-010-1147-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Effectiveness of a screening program for hepatitis C.

Authors:  Ramsey C Cheung; Barbara A Cunningham; Allen D Cooper
Journal:  Dig Dis Sci       Date:  2006-04-27       Impact factor: 3.199

2.  Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.

Authors:  Ava A John-Baptiste; George Tomlinson; Priscilla C Hsu; Mel Krajden; E Jenny Heathcote; Audrey Laporte; Eric M Yoshida; Frank H Anderson; Murray D Krahn
Journal:  Am J Gastroenterol       Date:  2009-06-30       Impact factor: 10.864

3.  A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection.

Authors:  Andrew J Muir; Dawn Provenzale
Journal:  J Clin Gastroenterol       Date:  2002-03       Impact factor: 3.062

4.  Effect of hepatitis C virus and its treatment on survival.

Authors:  Adeel A Butt; Xiaoqiang Wang; Charity G Moore
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

5.  Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.

Authors:  Sarah L George; Bruce R Bacon; Elizabeth M Brunt; Kusal L Mihindukulasuriya; Joyce Hoffmann; Adrian M Di Bisceglie
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

6.  Effect of race and HIV co-infection upon treatment prescription for hepatitis C virus.

Authors:  Adeel A Butt; Joel Tsevat; Anthony C Leonard; Obaid S Shaikh; Deborah McMahon; Uzma A Khan; Zachariah Dorey-Stein; Vincent Lo Re
Journal:  Int J Infect Dis       Date:  2008-11-06       Impact factor: 3.623

Review 7.  Hepatitis C and depression.

Authors:  W R Yates; O Gleason
Journal:  Depress Anxiety       Date:  1998       Impact factor: 6.505

8.  Psychiatric disorders among veterans with hepatitis C infection.

Authors:  Hashem B el-Serag; Mark Kunik; Peter Richardson; Linda Rabeneck
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

9.  The burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004.

Authors:  Robert P Myers; MingFu Liu; Abdel Aziz Shaheen
Journal:  Can J Gastroenterol       Date:  2008-04       Impact factor: 3.522

10.  Population-based hepatitis C surveillance and treatment in a national managed care organization.

Authors:  Deborah Shatin; Stephanie D Schech; Keyur Patel; John G McHutchison
Journal:  Am J Manag Care       Date:  2004-04       Impact factor: 2.229

View more
  5 in total

1.  Rate, delay and predictors of hepatitis C treatment in British Columbia.

Authors:  Alan Hoi Lun Yau; Terry Lee; Alnoor Ramji; Hin Hin Ko
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04-15

2.  Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.

Authors:  Maxine M Denniston; R Monina Klevens; Geraldine M McQuillan; Ruth B Jiles
Journal:  Hepatology       Date:  2012-04-10       Impact factor: 17.425

3.  Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study.

Authors:  Ivo Ditah; Badr Al Bawardy; Humberto C Gonzalez; Behnam Saberi; Callistus Ditah; Patrick S Kamath; Michael Charlton
Journal:  Am J Gastroenterol       Date:  2015-03-10       Impact factor: 10.864

4.  Quantifying potentially infectious sharing patterns among people who inject drugs in Baltimore, USA.

Authors:  M K Smith; M Graham; C A Latkin; S H Mehta; D A T Cummings
Journal:  Epidemiol Infect       Date:  2018-08-02       Impact factor: 2.451

5.  Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study.

Authors:  Terence L Johnson; Joshua C Toliver; Lu Mao; Christine U Oramasionwu
Journal:  BMC Infect Dis       Date:  2014-04-23       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.